|
GALC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92210700081341E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67643676718399E-12 |
| Normal-vs-Stage2 |
9.181400E-03 |
| Normal-vs-Stage3 |
2.94510000053982E-07 |
| Normal-vs-Stage4 |
5.543200E-03 |
| Stage1-vs-Stage2 |
1.842190E-01 |
| Stage1-vs-Stage3 |
8.458600E-01 |
| Stage1-vs-Stage4 |
5.880800E-01 |
| Stage2-vs-Stage3 |
2.600200E-01 |
| Stage2-vs-Stage4 |
2.053400E-01 |
| Stage3-vs-Stage4 |
4.828600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52655665885959E-13 |
| Normal-vs-AfricanAmerican |
1.52210000048392E-07 |
| Normal-vs-Asian |
9.166100E-02 |
| Caucasian-vs-AfricanAmerican |
1.612800E-01 |
| Caucasian-vs-Asian |
7.118800E-01 |
| AfricanAmerican-vs-Asian |
8.597600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29292149103821E-13 |
| Normal-vs-Female |
6.09220000002964E-08 |
| Male-vs-Female |
2.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.4864000030812E-09 |
| Normal-vs-Extreme_Weight |
9.10382880192628E-15 |
| Normal-vs-Obese |
7.98279999880691E-08 |
| Normal-vs-Extreme_Obese |
1.54649999473122E-08 |
| Normal_Weight-vs-Extreme_Weight |
3.750400E-01 |
| Normal_Weight-vs-Obese |
2.177200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.103600E-01 |
| Extreme_Weight-vs-Obese |
1.332410E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.213800E-01 |
| Obese-vs-Extreme_Obese |
9.334100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47190000188147E-08 |
| Normal-vs-Age(41-60Yrs) |
9.87879777980538E-11 |
| Normal-vs-Age(61-80Yrs) |
1.80333525889864E-12 |
| Normal-vs-Age(81-100Yrs) |
6.71360000925603E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.555620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.459800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.905800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.634960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.083190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.485800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04303240991521E-12 |
| Normal-VS-Type2 PRCC |
4.43522996107504E-12 |
| Normal-VS-KIRP CIMP |
3.0853997134983E-10 |
| Normal-VS-Unclassified PRCC |
7.383400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.183000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.975240E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.163600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.583500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.812440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.341680E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00550687168288E-12 |
| Normal-vs-N1 |
2.967700E-04 |
| Normal-vs-N2 |
6.70769999988607E-07 |
| N0-vs-N1 |
3.849600E-01 |
| N0-vs-N2 |
1.989980E-01 |
| N1-vs-N2 |
2.303200E-01 |
|
|
